Abstract
Data regarding the use of propranolol in pediatrics are limited despite its widespread use in adults. Since 1984, Propranolol has been used for the prevention of portal hypertensive hemorrhage in pediatric patients. Recently it has been also used for the managemnet of hemangiomas in addition to other indications. The purpose of this review is to evaluate safety and efficacy of propranolol use in the pediatric population, highlighting the most important reported side effects, warnings and precautions.
Keywords: Children, hemangioma, portal hypertension, propranolol, safety, side effects
Current Drug Safety
Title: Propranolol Safety Profile in Children
Volume: 6 Issue: 4
Author(s): Mortada El-Shabrawi and Fetouh Hassanin
Affiliation:
Keywords: Children, hemangioma, portal hypertension, propranolol, safety, side effects
Abstract: Data regarding the use of propranolol in pediatrics are limited despite its widespread use in adults. Since 1984, Propranolol has been used for the prevention of portal hypertensive hemorrhage in pediatric patients. Recently it has been also used for the managemnet of hemangiomas in addition to other indications. The purpose of this review is to evaluate safety and efficacy of propranolol use in the pediatric population, highlighting the most important reported side effects, warnings and precautions.
Export Options
About this article
Cite this article as:
El-Shabrawi Mortada and Hassanin Fetouh, Propranolol Safety Profile in Children, Current Drug Safety 2011; 6 (4) . https://dx.doi.org/10.2174/157488611798280889
DOI https://dx.doi.org/10.2174/157488611798280889 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Surgical Treatment of Neonatal Mastitis by Periareolar Drainage
Current Pediatric Reviews A Review of Patents on Therapeutic Potential and Delivery of Hydroge n Sulfide
Recent Patents on Drug Delivery & Formulation Melanotropins as Drugs for the Treatment of Obesity and Other Feeding Disorders: Potential and Problems
Current Topics in Medicinal Chemistry Gastric Mucosal Protection: From Prostaglandins to Gene-Therapy
Current Medicinal Chemistry Treatment of Hypertensive Left Ventricular Hypertrophy
Current Pharmaceutical Design The Role of “Eye Platelet Rich Plasma” (E-Prp) for Wound Healing in Ophthalmology
Current Pharmaceutical Biotechnology The ATP-driven Hsp60 Machinery: Biological and Clinical Implications
Current Immunology Reviews (Discontinued) Therapeutic Potential of Phosphodiesterase Inhibitors for Endothelial Dysfunction- Related Diseases
Current Pharmaceutical Design Recent Patents in Pemphigus Research, Prophylaxis, Diagnosis and Treatment in USA (1988-2006)
Recent Patents on Inflammation & Allergy Drug Discovery Recent advances in the management of autoimmune myocarditis: insights from animal studies.
Current Pharmaceutical Design The Role of the Antiangiogenetic Ramucirumab in the Treatment of Advanced Non Small Cell Lung Cancer
Current Medicinal Chemistry Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific
Current Drug Metabolism Organ- and Cell-Type Specific Delivery of Kinase Inhibitors: A Novel Approach in the Development of Targeted Drugs
Current Molecular Pharmacology Kinetic Resolution of (R,S)-atenolol with the Use of Lipases in Various Organic Solvents
Current Organic Synthesis Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection?
Current Drug Targets Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD)
Current Pharmaceutical Design New Insight Into A1 Adenosine Receptors in Diabetes Treatment
Current Pharmaceutical Design Lung Structural Changes in Chronic Obstructive Pulmonary Diseases
Current Drug Targets - Inflammation & Allergy Novel Inflammatory Indices in Aortic Disease
Current Medicinal Chemistry Genetic and Molecular Determinants of Atherosclerotic Plaque Instability
Current Vascular Pharmacology